NOVOCURE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MAYER BROWN LLP	—	5

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	4
SENATE	4
U.S. Trade Representative (USTR)	4
Food & Drug Administration (FDA)	3

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	4
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	1
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

NOVOCURE — Lobbying Disclosure | Poliscope